Also known as Arimidex
Anastrozole (INN) (marketed under the trade name Arimidex by AstraZeneca) is an aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and post-menopausal women. The severity of breast cancer is increased by estrogen, as sex hormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen. The patent on Arimidex by AstraZeneca expired June 2010.Source: Wikipedia
Estimated Total Cost: $229.51 for an average of 28 days supply
Patients are most commonly prescribed anastrozole to treat breast cancer, metastatic cancer, mastectomy, and bone disorder.
Patients taking anastrozole most commonly experience side effects like nausea, flushing, and headache.
|Heart attack (MI)|
|Shortness of breath|
|Bones are painful|